| Recruiting | 3 | 548 | Europe, RoW | abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin | Abnoba Gmbh | Superficial Bladder Cancer | 06/28 | 12/28 | | |
| Recruiting | 3 | 548 | Europe, RoW | abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin | Abnoba Gmbh | Superficial Bladder Cancer | 06/28 | 12/28 | | |
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) |
|
|
| Active, not recruiting | 3 | 900 | Europe, Canada, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib | Eli Lilly and Company | Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6 | 02/24 | 10/27 | | |
| Recruiting | 3 | 548 | Europe, RoW | abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin | Abnoba Gmbh | Superficial Bladder Cancer | 06/28 | 12/28 | | |
